Press "esc" to clear
Go to Advanced Search

Showing results

192881192890 of 198720

Article ID: 10020

Treating Common Outpatient Bacterial Infections

SmithKline Beecham (now GlaxoSmithKline)

As part of the nationally-coordinated ALERT, A Local Evaluation of Resistance Trends, 47 hospitals nationwide have contributed to a collection of data focused on the increase in antibiotic resistance.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10019

Chicago Loop Office Space Shrinking

University of Illinois at Chicago

A study conducted by the Center for Urban Real Estate at the University of Illinois at Chicago shows a downtown real estate marketplace with a growing problem: premier office space is shrinking in one of the nation's tightest real estate markets.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10018

Squirrel-Squelchers for Bird Feeders

Cornell University

From the 13,000 volunteers who count birds for science in the continentwide Project FeederWatch, Cornell University ornithologists have collected solutions for birders who prefer not to count squirrels.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Pop Culture

Article ID: 10016

New Cancer Drug Tested

University Hospitals Cleveland Medical Center

A cancer patient at the Ireland Cancer Center at University Hospitals of Cleveland is the first person in the world to be treated with a new class of drugs that targets and destroys cancer-feeding blood vessels.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10015

Extreme Heat-Loving Organisms May Be Key To Molecular Evolution

University of Georgia

Extreme heat-loving organisms may be the key to molecular evolution, origin of life, according to new book by University of Georgia scientists.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10014

New Data on Phen-Fen Diet Drugs

University of California, Irvine

Patients who took the diet drug Redux (dexfenfluramine) or a drug combination known as "phen-fen" for longer than three months showed some cardiovascular abnormalities, but at levels not currently regarded as clinically significant, according to a study to be presented today by a UC Irvine College of Medicine researcher at the American Heart Association's Annual Scientific Sessions.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10013

Clinical Guidelines for Herbal Therapies

Perelman School of Medicine at the University of Pennsylvania

University of Pennsylvania Medical Center physicians have developed a list of clinical guidelines to aid physicians in advising patients about herbal products as therapeutic agents.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10012

Future Car Receives Fuel Cell

Texas Tech University

Texas Tech University's FutureCar Research is receiving an energy boost from Energy Partners, Inc. of West Palm Beach, Fla. The company is donating a hydrogen-powered fuel cell that Texas Tech will install in a Chevrolet Lumina when the cell arrives the first week of December.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10011

Lesbian Physicians to Meet in Tucson

Gay and Lesbian Medical Association (GLMA)

Hundreds of lesbian physicians and medical students from throughout the United States and Canada will gather in Tucson, Ariz., April 8-11, for the 16th annual Women in Medicine (WIM) conference.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 10010

Metoprolol Improves Survival in Heart Failure Patients

Astra Pharmaceuticals

Adding the beta blocker Toprol-XL to standard treatment in patients with congestive heart failure can help reduce all-cause mortality and improve survival by about 35 percent, according to the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure.

Released:
12-Nov-1998 12:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

192881192890 of 198720





Chat now!